Individual Solutions for Doctors and Patients
We help doctors and patients make informed decisions and create targeted treatment plans and personalized therapies for cancer.
At the Frontier of Personalized Oncology
RGCC specializes in cancer research and personalized cancer therapy. We develop innovative diagnostic procedures and therapies against cancer. We have been offering our expertise to doctors and patients in our global laboratory network since 2004. Find out here how we are continuously expanding the possibilities for diagnosing and treating cancer with the help of personalized blood tests and analyses of circulating tumor cells, circulating tumor DNA and other biomarkers.
Speak with Your Doctor about RGCC
RGCC cancer blood tests can be used as an adjunct to other diagnostic procedures as part of personalized medical treatment and should not be used solely for definitive diagnoses. Our wide array of blood tests can provide valuable information and help monitor cancers, identify genetic changes and tailor treatment.
As these tests can vary depending on the type of cancer and individual circumstances, patients should speak to their oncologist about the most appropriate blood test for their specific health condition and diagnosis. We invite you to learn more about the RGCC testing procedures: Here you will find detailed information on tests and therapies. Alternatively, you can also contact us directly to ask questions or obtain further information about our services. Our technical experts will be happy to help you with your inquiry.
Cancer Blood Tests from RGCC International
New methods and reliable tests for personalized cancer therapy
In recent years, significant progress has been made in the development of testing for cancer diagnosis. These tests are often referred to as "liquid biopsy" as they can provide a better understanding about the cancer by looking for biomarkers in the blood. RGCC laboratories are among the leading scientific sites in cancer medicine research worldwide. In addition to continuous research into new detection methods, we offer tests for doctors to help them create a personalized cancer treatment plan for their patients and adjust it according as necessary. Our tests are therefore to discover, analyse and screen cancer cells at every step of the disease.
Circulating Tumor DNA Tests (ctDNA Tests)
Cancer cells can have genetic changes that are specific to the tumor. ctDNA tests look for tiny amounts of circulating tumor DNA in the blood. These tests can be used to confirm the presence of cancer, monitor tumor burden, and identify genetic alterations that may be helpful in selecting treatment options.
Protein-Based Blood Tests
These cancer tests look for specific proteins that are released by cancer cells, such as tumor markers. A well-known example is the PSA test (prostate specific antigen), which is used in the diagnosis of prostate cancer. Other protein markers that are associated with different types of cancer are also being researched.
Liquid Biopsy Tests
These more comprehensive tests look for different types of biomarkers in the blood, including circulating tumor DNA, cell-free RNA, proteins and circulating tumor cells. Liquid biopsies can provide information about the presence of cancer, genetic changes in the body, the effectiveness of treatment and the progression of the disease.
Patients should talk to their oncologist or treating physician about the alternative cancer tests that are suitable for their diagnosis, as these differ depending on the type of cancer and individual circumstances. Our tests have undergone clinical trials with different groups of people and, can be used to detect different types of cancer, like lung cancer, breast cancer or prostate cancer. Would you like to learn more about the different test methods used at RGCC? Read about our tests here or get in touch with us.
RGCC Tests
New methods and reliable tests to facilitate a personalized treatment
-
Onco-D-clare
Onco-D-Clare is an early cancer detection test based on the synergy of molecular biology and artificial neural networks.
-
InVyomma Plus
focuses on gut microbiome profiling, including analysis of short-chain fatty acids, and how they are associated with…
-
Onconomics Extracts +
Onconomics Extracts+ provides highly detailed and accurate information about how effective specific natural substances and plant extracts are. Furthermore,…
-
Oncocount
RGCC detects the presence of circulating tumor cells (CTCs) and their concentration in the blood. CTCs are a…
-
Oncotrace
RGCC detects the presence of circulating tumor cells (CTCs), their concentration on the blood, as well as their…
-
Oncotrail
RGCC provides crucial information on the presence of circulating tumor cells (CTCs) and their concentration in patients who…
-
Onconomics
RGCC provides highly detailed and accurate information about how effective specific anti-cancer drugs and targeted therapies are in…
-
Onconomics Plus
RGCC provides information about the effect of specific anti-cancer drugs, targeted therapies and natural treatments on the…
-
Onconomics Extracts
is a unique and highly detailed test that provides information on how effective natural substances and plant…
-
ChemoSNiP
is an inovative test that uses molecular biology techniques to analyze how patient's body will respond (metabolize) to…
-
Metastat
RGCC is an advanced test to detect specific blood-borne markers that can accurately determine whether a secondary cancerous…
-
Immune-Frame
is used to assess the condition of a patient’s immune system. Scientists use the test to identify specific…
-
aCGH
The array comparative genomic hybridisation (aCGH) RGCC test is used to identify chromosomal abnormalities in a patient that could…
-
RGCC CAMBISeq®
(Cancer Analysis, Mutational Burden and Instability Sequencing) is an innovative test that uses next-generation sequencing analysis on…
Use our ‘smart filter’ to identify which test is best for your patients
Personalized Medicine: Information for Patients
We offer cancer patients a range of personalized tests so that together with their treating physician they can choose the treatment method that is right for them. We also provide a guide for patients to gain understanding of their disease and new treatment options. Learn more about how we empower patients.
Personalized Cancer Therapy
The latest generation of cancer therapy: We support existing treatment approaches with immunotherapy, SOT and adoptive T-cell therapy. We also offer treatments methods for other chronic illnesses like lyme disease.
Q-REstrain
Q-REstrain consists of microRNA molecules with the ability to regulate the gene expression of a specific target. The short dsRNAs (double-stranded RNAs) are derived by cleavage of long dsRNA from Dicer and can be microRNAs (miRNAs). miRNAs then assemble with RNA-induced silencing complex (RISC) and cause gene silencing. RNAi has been used in the therapy of different diseases including cancer, viral infections, respiratory diseases, etc. Targeting of specific proteins, through degradation of their mRNA, is very common in cancer treatment of different types of cancer or other infections.
Q-REstrain contains microRNAs isolated by the patient’s sample, leading to the degradation of specific mRNA molecules, which are overexpressed in this specific sample, thus regulating the expression. Q-REstrain is for autologous use only and is provided through the RGCC network.
Clavic-Q-RE
Clavic-Q-RE is an adoptive cell therapy aiming to generate a robust anti-tumor immune response. Clavi-Q-RE contains different cell populations, isolated by the patient’s sample. They include monocytes, natural killer cells, as well as dendritic cells that are already activated in vivo against tumor antigens, which are expressed on cancer samples, cytotoxic T lymphocytes, and plasma cells that have been already differentiated in vivo against tumor antigens. Clavic-Q-RE is for autologous use only and is provided through the RGCC network.
Vaccine Prep (ATA)
Vaccine Prep (ATA) is a new type of immunotherapy that activates or strengthens specific immune cells. The body's own cells are specifically designed to recognize and destroy cancer cells. We use the cellular fragments of dying tumor cells (CTCs). These include organelles, mitochondria, cell membranes and cellular RNA and DNA. In our laboratory, we stimulate the development of dendritic cells and thus promote tumor antigen therapy.
Dendritic cell therapy
The aim of dendritic cell therapy is to activate or strengthen the immune system. In immunotherapy, specific immune cells are used to target cancer cells. The therapy method uses so-called dendritic cells, which can recognize specific antigens on the surface of cancer cells. Thanks to improved tumor defense and a reduction in systemic side effects, the therapy is considered a promising treatment approach.
In cancer medicine, the choice of suitable therapy depends on the type of tumor, the stage of the disease and the patient's individual condition. Our therapies have gone through several clinical trials and can be an option for different groups of people as part of a personalized cancer treatment. We have compiled more information on the individual RGCC cancer therapies for you on our therapies overview page.
Testimonials
-
PatientP
P.W. (Europe)
RGCC Laboratory has been a beacon of reliability and compassion in my cancer journey. Their cutting-edge tests not only provided me with a clear understanding of my diagnosis but also…
PP.W. (Europe)
RGCC Laboratory has been a beacon of reliability and compassion in my cancer journey. Their cutting-edge tests not only provided me with a clear understanding of my diagnosis but also guided my treatment decisions every step of the way. The peace of mind that comes from knowing I'm receiving the most advanced care possible is invaluable. I can't thank RGCC enough for their unwavering commitment to patients like me.
-
PatientB
B.T. (North America)
I have been involved with RGCC through my doctor for the last four years, due to early-stage breast cancer. Once a year I have done the Onconomics Plus, the Oncotrace…
BB.T. (North America)
I have been involved with RGCC through my doctor for the last four years, due to early-stage breast cancer. Once a year I have done the Onconomics Plus, the Oncotrace blood/lab work. I have faithfully used the Onconomics Plus recommended supplements over the last four years. I can report that these modalities, together with lifestyle changes, have had a marked diminishing effect on my Circulating Tumor Cells (CTC), and keep them in a “low range”. Additionally, follow-up mammograms and ultrasounds show the small areas of concern in my breast have not increased in size! I also had a small vaginal “cyst” that completely disappeared. I sincerely believe that all of my RGCC-recommended treatments have been beneficial and have had a very healing and positive impact on my health over the last four years. I feel certain that through this early intervention, I have avoided much more serious breast cancer concerns in the future. I also feel it’s very important to treat other viruses or ailments, as they wear the immune system down, impacting our body’s ability to function optimally & self-correct other potentially larger problems that may be brewing under the surface. I truly feel that due to the insight of my doctor, who ordered the first RGCC lab work, I have been able to address the early-stage breast cancer concerns well in advance of the traditional medical community’s ability to detect any areas of concern. Note: None of my previous annual mammograms revealed any areas of concern. On a gut feeling, I self-paid for a “Her Scan” ultrasound, which discovered the two small areas of concern in my right breast. After sharing this information with my doctor, he encouraged me to do the RGCC labs, revealing the Circulating Tumor Cells and gene mutations. I feel that without RGCC’s early diagnosis and intervention, I was headed toward serious health challenges, potentially resulting in a full-blown breast cancer diagnosis in my future. I strongly encourage people to become involved with RGCC’s cutting-edge medical technologies and treatments. It helped me!
-
PatientM
M. T. (Southeast Asia)
I felt lost after my colon cancer diagnosis. Traditional treatment options seemed harsh, and I craved a more holistic approach. Then I found RGCC. The blood test identified underlying issues…
MM. T. (Southeast Asia)
I felt lost after my colon cancer diagnosis. Traditional treatment options seemed harsh, and I craved a more holistic approach. Then I found RGCC. The blood test identified underlying issues beyond the cancer itself. I feel more empowered to take control of my healing journey. RGCC gave me a second chance, and I’m determined to make the most of it.
-
PatientL
L.O. (North America)
RGCC has been an integral part of my healing journey for the past 5 years. It has allowed me to receive specialized treatments for MY cancer. After being diagnosed with…
LL.O. (North America)
RGCC has been an integral part of my healing journey for the past 5 years. It has allowed me to receive specialized treatments for MY cancer. After being diagnosed with Breast Cancer I felt like I was put on the conveyor belt of conventional therapies. Doctors were not looking at me as a person, just as the disease. When I would ask about the Why behind things, I was generally told "because that's how we treat breast cancer." I never felt like they were treating me. I knew something was missing. That's when I began to seek out other therapies. I found an amazing Integrative Doctor who led me to RGCC. As soon as I read the information about RGCC's specialized options for ME, I knew I had found my path. Since starting RGCC I have never felt better. My CTC was 5.6 (which is aggressive for breast cancer) and I am currently at 1.9 without chemo or radiation. I will continue until I reach 0. RGCC has helped save my life. I would highly recommend it to anyone considering alternative treatments. I opt to get the Onconomics Plus yearly so I can see which supplements are working best against my cancer. I am always amazed at how much my cancer has adapted to the supplements from year to year. RGCC is specific for you and your cancer cells in real-time. I now help others navigate their cancer diagnosis, so I see RGCC reports often, and I've never seen 2 be anywhere close to the same. What does that say for the Conventional medical model? We are unique individuals and so are our cancer cells. Thank you to all the Scientists and Doctors who have given me a way to monitor my cancer cells in real time. You have indeed saved my life.
-
Doctor / Clinician
Dr. Tristin Wallace, ND
Inspiration Health & Wellness
RGCC's sensitive cell count test identified my patient's circulating malignant breast cancer cells.
Dr. Tristin Wallace, ND
Inspiration Health & Wellness
RGCC's sensitive cell count test identified my patient's circulating malignant breast cancer cells.
-
Doctor / Clinician
Dr. Christine Stueve, D.PSc., PhD, ND, DMBM
Founder NSIPM, Sano Consulting & Wellness Center, Lakeville, USA
I must express my gratitude and thankfulness for the incredible brilliance of the RGCC team. I had a large breast tumor in 2007 that was handled without chemo, radiation or…
Dr. Christine Stueve, D.PSc., PhD, ND, DMBM
Founder NSIPM, Sano Consulting & Wellness Center, Lakeville, USA
I must express my gratitude and thankfulness for the incredible brilliance of the RGCC team. I had a large breast tumor in 2007 that was handled without chemo, radiation or surgery. I did not know about RGCC until 2016 when the remaining CSCs and CTCs were discovered. As aggressive as these mutated cells have presented, I surely would have had recurrence in multiple areas of my system. For my clients, I see a massive difference as I partner with RGCC assessments and walk them through resolving trauma and unresolved stress patterns. I am forever grateful for Dr. Papasotiriou and the RGCC team!
-
Doctor / Clinician
Prof. Dr. Med. Joachim Drevs
UNIFONTIS Praxis für integrative Onkologie, Sickte, Germany
It is a true pleasure to speak about our partnership with RGCC Laboratory. Their tireless dedication to excellence and unparalleled reliability makes them a cornerstone of our oncological practice. RGCC…
Prof. Dr. Med. Joachim Drevs
UNIFONTIS Praxis für integrative Onkologie, Sickte, Germany
It is a true pleasure to speak about our partnership with RGCC Laboratory. Their tireless dedication to excellence and unparalleled reliability makes them a cornerstone of our oncological practice. RGCC Laboratory has established itself as a leading provider of cancer tests, and their advanced technologies enable us to develop precise and personalized treatment plans for our patients. The expertise and commitment of the RGCC team are unmatched. Their ability to combine innovative research with practical applicability has elevated our patient care to a new level. Through their comprehensive tests, we can not only make an accurate diagnosis but also identify the best therapy options for each individual patient. Furthermore, RGCC stands out for its outstanding customer support. Their team is always there to ensure that our questions are answered, and our needs are met. Their professionalism and commitment to excellent service are evident in every interaction. In our oncological practice, we have the confidence that RGCC Laboratory provides us with the highest quality and most reliable cancer tests available on the market. Their work is not only an asset to our practice but, most importantly, to our patients, who benefit from the precise diagnoses and personalized treatment plans. We are proud to partner with RGCC Laboratory and look forward to a continued successful partnership that enables us to provide our patients with the best possible care.
-
PatientS
S.L. (Europe)
From the moment I stepped into the Clinic, I knew I was in good hands, as they work closely with RGCC Laboratory. Their dedication to precision and personalized care is…
SS.L. (Europe)
From the moment I stepped into the Clinic, I knew I was in good hands, as they work closely with RGCC Laboratory. Their dedication to precision and personalized care is unmatched. Thanks to their tests, my treatment plan was tailored specifically to my needs, giving me the best possible chance at beating cancer. I'm forever grateful for their expertise and support during this challenging time.
-
PatientL
L.K. (Europe)
I can't thank RGCC Laboratory enough for their incredible diagnostic options throughout my cancer journey. Their tests provided me with the accurate diagnosis I needed to start my treatment plan.…
LL.K. (Europe)
I can't thank RGCC Laboratory enough for their incredible diagnostic options throughout my cancer journey. Their tests provided me with the accurate diagnosis I needed to start my treatment plan. Knowing that my care team had access to such reliable information gave me the confidence to face each day with hope. RGCC's commitment to excellence truly made a difference in my life.
-
Doctor / Clinician
Dr. Ana Paz
White Clinic, Lisbon, Portugal
For the past decade, my clinical practice has been divided between daily clinical activity and scientific research. Oral-systemic health connection has been always our mission at the White Clinic, especially…
Dr. Ana Paz
White Clinic, Lisbon, Portugal
For the past decade, my clinical practice has been divided between daily clinical activity and scientific research. Oral-systemic health connection has been always our mission at the White Clinic, especially the missing link for many chronic diseases such as cancer and autoimmune diseases. Part of my challenge has been to seek state of the art diagnostic tools that can help my patient heal faster. It is without any obstacle or any limitation that this constant pursuit of scientific advancement led me to RGCC and I am profoundly grateful to the team, scientific board and the founder for developing something so unique and so precise that allows me to truly help my patients thrive. We are all part of a community of healers, and it is our duty to connect as many dots as possible and I am truly grateful to the science in this testing and therapies. Our patients are deeply thankful.
-
PatientM
M. (Europe)
I was diagnosed with stage 3 Colon Cancer in 2021. After going through surgery to remove the tumor, my Oncologist suggested that I immediately start Chemotherapy or else I would…
MM. (Europe)
I was diagnosed with stage 3 Colon Cancer in 2021. After going through surgery to remove the tumor, my Oncologist suggested that I immediately start Chemotherapy or else I would definitely die of Cancer. I had heard of RGCC and the different targeted therapies they offer to fight circulating tumor cells and I was very eager to try. I highly recommend RGCC liquid biopsy to everyone I engaged in health-related conversations with. Having not only the RGCC therapies available to people seeking a cure but also the peace of mind that comes with periodic liquid biopsy testing to monitor our health progression is a must.
-
PatientR
R. (Europe)
For many years I have experienced problems commonly referred to as lyme disease and this diagnosis has been confirmed by various doctors including blood tests. These were dozens of different…
RR. (Europe)
For many years I have experienced problems commonly referred to as lyme disease and this diagnosis has been confirmed by various doctors including blood tests. These were dozens of different non-specific symptoms that fundamentally made my life unpleasant. Long-term treatment with ATB and various herbal preparations helped me but did not cure it. As well as many alternative methods that cost me just a lot of money. Finally, SOT fundamentally improves my quality of life, and blood tests confirm this trend. I want to continue with this treatment because I think it is definitely the best investment so far.
Join the RGCC Network
The innovative, alternative therapies against cancer and other chronic diseases of the RGCC laboratories are exclusively available to doctors in our RGCC network. Find out how you can become part of our network:
News & Events
Learn more about our research, the latest publications and RGCC events.
-
News
RGCC and PERABOI Sign MOU for a Clinical Study on Circulating Tumor Cells in Breast Cancer
October 4th, 2024 – Bali, Indonesia: RGCC, a leader in advanced diagnostic technologies, and the Indonesian Association of Surgical…
-
Events
RGCC Participates in Indonesia International Cancer Conference
Bali, Indonesia
RGCC is proud to have participated in the Indonesia International Cancer Conference (IICC) held from 3-5 October 2024
-
Events
RGCC North America Gathering 2024: Advancing Cancer Care Through Collaboration and Innovation
Denver, Colorado
The RGCC North America Gathering 2024 took place from 17-19 October 2024 at the Denver Marriott Tech Center, bringing…
-
News
Applications now open for the Cancer Drug Discovery Research Award
The Cancer Drug Discovery Research Award, supported by RGCC International and The Swiss Chemical Society is here to honor…
-
News
RGCC SA laboratory in Greece receives prestigious certification from Japan’s Ministry Of Health, Labour and Welfare
Japan
RGCC SA is proud to announce that our state-of-the-art laboratory in Greece has been awarded the accreditation certificate of…
-
News
RGCC Unveils Revolutionary Cancer Detection Test, Onco-D-clare
RGCC announces the launch of Onco-D-clare, a groundbreaking cancer detection test that marks a significant milestone in early cancer…